Senores Pharmaceuticals Ltd
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 |
|---|---|---|---|
| Revenue | 50.41 | 36.54 | 59 |
| Operating Expense | 34.59 | 29.32 | 40.29 |
| Net Profit | 7.72 | 1.03 | 8.48 |
| Net Profit Margin | 15.31% | 2.82% | 14.37% |
| Earning Per Share | 1.68 | 0.22 | 1.84 |
| EBIDTA | 15.88 | 7.17 | 20.98 |
| Effective Tax Rate | 12.71% | 4.29% | 34.63% |
Particulars
Sep 2026
Revenue50.41
Operating Expense34.59
Net Profit7.72
Net Profit Margin15.31
Earning Per Share1.68
EBIDTA15.88
Effective Tax Rate12.71
